Adirondack Trust Company’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6K Hold
860
0.01% 365
2026
Q1
$13.7K Hold
860
﹤0.01% 363
2025
Q4
$22.6K Hold
860
0.01% 319
2025
Q3
$19.4K Hold
860
0.01% 342
2025
Q2
$17.1K Hold
860
0.01% 322
2025
Q1
$14.5K Hold
860
0.01% 321
2024
Q4
$15.9K Hold
860
0.01% 319
2024
Q3
$18.7K Hold
860
0.01% 316
2024
Q2
$16.9K Hold
860
0.01% 318
2024
Q1
$18.7K Hold
860
0.01% 308
2023
Q4
$19.4K Hold
860
0.01% 301
2023
Q3
$23K Hold
860
0.01% 273
2023
Q2
$33.4K Hold
860
0.02% 234
2023
Q1
$26.8K Hold
860
0.01% 246
2022
Q4
$25.6K Hold
860
0.01% 247
2022
Q3
$33K Hold
860
0.02% 225
2022
Q2
$47K Hold
860
0.03% 194
2022
Q1
$54K Buy
860
+130
+18% +$8.56K 0.03% 193
2021
Q4
$73K Buy
730
+60
+9% +$5.27K 0.03% 171
2021
Q3
$56K Hold
670
0.03% 183
2021
Q2
$62K Hold
670
0.03% 171
2021
Q1
$65K Buy
670
+50
+8% +$5.16K 0.03% 165
2020
Q4
$69K Buy
+620
New +$25.9K 0.04% 153

Other funds holding FLGT

Adirondack Trust Company's FLGT Position: Q2 2026 in Review

Adirondack Trust Company held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 860 shares worth $17.6K. The position accounts for 0.01% of the portfolio, ranked #365.

Adirondack Trust Company first reported a position in FLGT in Q4 2020 and has held it in 23 quarters since. The position peaked at $73K in Q4 2021. 19 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Adirondack Trust Company held 860 shares of Fulgent Genetics worth $17.6K as of Q2 2026.
  • Adirondack Trust Company left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up 0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #365 holding.
  • Adirondack Trust Company first reported a position in Fulgent Genetics in Q4 2020 and has held it in 23 quarters since.
  • Adirondack Trust Company's Fulgent Genetics position peaked at $73K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.